Qventis – Pioneering Bionic Solutions in Regenerative Aesthetics

Qventis is a forward-thinking medical device company based in Germany, committed to developing and delivering innovative, bionic-inspired medical solutions for tissue regeneration and aesthetic restoration. Rooted in a biomimetic philosophy—“learning from nature, powered by science”—Qventis focuses on crafting native-like or bioidentical formulations, primarily using hyaluronic acid (HA), to elevate regenerative outcomes and enhance patient well‑being.

Under its RENÉE range, Qventis offers an advanced lineup of monophasic, cross-linked HA gels designed for facial rejuvenation—addressing needs from hydration and fine-line correction to volumizing and contouring. Leveraging proprietary Bionic Design, each RENÉE gel mimics the structure and rheology of the body’s extracellular matrix, delivering seamless integration, high elasticity, cohesivity, and excellent tissue compatibility. These products are engineered to support precise, predictable outcomes, minimal bruising or swelling, and enjoyable treatment experiences for both practitioners and patients.

With a strong emphasis on research, Qventis secured full EU MDR certification for the RENÉE portfolio in 2024, underlining its dedication to safety, efficacy, and clinical quality. The company continues to contribute widely to medical aesthetics education and innovation, showcasing its work at global aesthetic congresses.

Qventis delivers more than fillers—it provides regenerative, science-driven solutions that empower practitioners with trusted instruments to enhance natural beauty harmoniously and responsibly.